Trials / Conditions / Second-line
Second-line
3 registered clinical trials studyying Second-line — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrosp NCT06814548 | Yongxu Jia | — |
| Recruiting | Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastri NCT05927857 | National Health Research Institutes, Taiwan | Phase 1 / Phase 2 |
| Unknown | Second-Line Irinotecan vs. ILF for AGC NCT00509964 | Gachon University Gil Medical Center | Phase 2 |